(Q67595988)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:882156%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

title

Canrenoate disposition in dogs. Tissue distribution and elimination (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:882156%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

author name string

J. Kuhlmann

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A882156

4 August 2022

V. Kötter

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A882156

4 August 2022

N. Rietbrock

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A882156

4 August 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=882156

4 August 2022

publication date

1 June 1977

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:882156%20AND%20SRC:MED&resulttype=core&format=json

Naunyn-Schmiedeberg's Archives of Pharmacology

15 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:882156%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

volume

298

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:882156%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:882156%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

page(s)

181-187

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:882156%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00508627

15 September 2019

exact match

0 references

cites work

Spironolactone metabolism in man studied by gas chromatography-mass spectrometry

1 reference

12 December 2020

Blocking the renal electrolyte effects of mineralocorticoids with an orally active steroidal spirolactone

1 reference

12 December 2020

Prediction of Stability in Pharmaceutical Preparations XVI: Kinetics of Hydrolysis of Canrenone and Lactonization of Canrenoic Acid

1 reference

12 December 2020

Isolation and identification of novel sulfur-containing metabolites of spironolactone (Aldactone®)

1 reference

12 December 2020

ALDOSTERONE AND ALDOSTERONISM. NEW RESULTS AND EXPERIENCES

1 reference

12 December 2020

Use of Potassium Canrenoate to Suppress Ouabain-Induced Ventricular Arrhythmias in Dogs

1 reference

12 December 2020

Reduced aldosterone secretion during spironolactone treatment in primary aldosteronism: report of a case

1 reference

12 December 2020

Prevention of Digitoxin Poisoning by Various Steroids

1 reference

12 December 2020

Isolation and identification of a sulfur-containing metabolite of spironolactone from human urine

1 reference

12 December 2020

Pharmacokinetics of spironolactone, canrenone and canrenoate-K in humans

1 reference

12 December 2020

Suppression by the spironolactone metabolite canrenone of plasma testosterone in man

1 reference

12 December 2020

1 reference

12 December 2020

ALDOSTERONE AND ITS ANTAGONISTS.

1 reference

12 December 2020

Disposition of Tritium-Labeled Spirolactones in the Dog

1 reference

12 December 2020

[Experimental and clinical findings on treatment of cardiac-glucoside intoxication]

1 reference

12 December 2020

Spironolactone--a weak enzyme inducer in man.

1 reference

12 December 2020

Effect of spironolactone and norbolethone on the toxicity of digitalis compounds in the rat

1 reference

12 December 2020

Antifibrillatory effects of electrolyte-regulating steroids on isolated rabbit atria

1 reference

12 December 2020

Positive-inotropic heart effect of aldadiene-potassium (Aldactone pro injections)

1 reference

12 December 2020

PHARMACOLOGICAL PROPERTIES OF A MINERALOCORTICOID ANTAGONIST (SC-14266)

1 reference

12 December 2020

Spironolactone. I. Disposition and metabolism

1 reference

12 December 2020

Conversion of spironolactone to canrenone and disposition kinetics of spironolactone and canrenoate-potassium in rats

1 reference

12 December 2020

Possible mechanism of the prevention of digitoxin toxicity by spironolactone in the mouse

1 reference

12 December 2020

Species differences in the metabolism and disposition of spironolactone

1 reference

12 December 2020

Inhibition of aldosterone production in diuretic-induced hyperaldosteronism by aldosterone antagonist canrenone in man.

1 reference

12 December 2020

Direct positive inotropic cardiac effect of aldactone (spironolactone, canrenoate-K)

1 reference

12 December 2020

On the mechanism of the inhibitory action of the spirolactone SC 9376 (aldadiene) on the production of corticosteroids in rat adrenals in vitro

1 reference

12 December 2020

Plasma Levels of Spirolactones in the Dog

1 reference

12 December 2020

Pharmacokinetic and Metabolic Fate of Potassium Canrenoate (SC-14266) in Man

1 reference

12 December 2020

Molecular modifications of anti-aldosterone compounds: effects on affinity of spirolactones for renal aldosterone receptors

1 reference

12 December 2020

Digitoxin poisoning: prevention by spironolactone

1 reference

12 December 2020

Prevention and abolition of ouabain-induced ventricular tachycardia by potassium canrenoate in dogs

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00508627

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:882156%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

15 September 2019

0 references

1 reference